Kidney drug trial halted early: what happened with VB119?
Disease control
Terminated
This early-stage study tested a new drug, VB119, in 6 adults with primary membranous nephropathy, a kidney disease that can lead to kidney failure. The goal was to check the drug's safety and see if it could help patients achieve remission. The study was terminated early, so resu…
Phase: PHASE1, PHASE2 • Sponsor: Tenet Medicines • Aim: Disease control
Last updated May 18, 2026 11:44 UTC